FR2949464B1 - Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique - Google Patents

Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique

Info

Publication number
FR2949464B1
FR2949464B1 FR0904137A FR0904137A FR2949464B1 FR 2949464 B1 FR2949464 B1 FR 2949464B1 FR 0904137 A FR0904137 A FR 0904137A FR 0904137 A FR0904137 A FR 0904137A FR 2949464 B1 FR2949464 B1 FR 2949464B1
Authority
FR
France
Prior art keywords
oxadiazoles
thiadiazoles
derivatives
preparation
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0904137A
Other languages
English (en)
Other versions
FR2949464A1 (fr
Inventor
Eykmar Fett
Patrick Mougenot
Claudie Namane
Eric Nicolai
Christophe Philippo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0904137A priority Critical patent/FR2949464B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to BRPI1007414-7A priority patent/BRPI1007414A2/pt
Priority to KR1020117019841A priority patent/KR20110112845A/ko
Priority to EA201170983A priority patent/EA201170983A1/ru
Priority to ARP100100186A priority patent/AR075177A1/es
Priority to NZ594244A priority patent/NZ594244A/xx
Priority to CN2010800142290A priority patent/CN102365273A/zh
Priority to PCT/FR2010/050124 priority patent/WO2010086551A1/fr
Priority to US13/145,665 priority patent/US8546391B2/en
Priority to MA34128A priority patent/MA33069B1/fr
Priority to PE2011001392A priority patent/PE20120362A1/es
Priority to JP2011546921A priority patent/JP2012516312A/ja
Priority to EP10707597.0A priority patent/EP2391611B1/fr
Priority to MX2011007991A priority patent/MX2011007991A/es
Priority to AU2010209545A priority patent/AU2010209545A1/en
Priority to CA2750742A priority patent/CA2750742A1/fr
Priority to TW099102288A priority patent/TW201031645A/zh
Priority to UY0001032405A priority patent/UY32405A/es
Publication of FR2949464A1 publication Critical patent/FR2949464A1/fr
Priority to TN2011000353A priority patent/TN2011000353A1/fr
Priority to IL214260A priority patent/IL214260A0/en
Priority to EC2011011224A priority patent/ECSP11011224A/es
Priority to CR20110403A priority patent/CR20110403A/es
Priority to NI201100149A priority patent/NI201100149A/es
Priority to ZA2011/05525A priority patent/ZA201105525B/en
Priority to CL2011001839A priority patent/CL2011001839A1/es
Priority to DO2011000245A priority patent/DOP2011000245A/es
Priority to CO11094698A priority patent/CO6400221A2/es
Publication of FR2949464B1 publication Critical patent/FR2949464B1/fr
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0904137A 2009-01-28 2009-09-01 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique Expired - Fee Related FR2949464B1 (fr)

Priority Applications (27)

Application Number Priority Date Filing Date Title
FR0904137A FR2949464B1 (fr) 2009-09-01 2009-09-01 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique
TW099102288A TW201031645A (en) 2009-01-28 2010-01-27 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
CA2750742A CA2750742A1 (fr) 2009-01-28 2010-01-27 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique
ARP100100186A AR075177A1 (es) 2009-01-28 2010-01-27 Derivados de tiadiazoles y oxadiazoles, metodo de preparacion, intermediarios de sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad y diabetes, entre otros.
NZ594244A NZ594244A (en) 2009-01-28 2010-01-27 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
CN2010800142290A CN102365273A (zh) 2009-01-28 2010-01-27 噻二唑与*二唑衍生物及其制备与其治疗用途
PCT/FR2010/050124 WO2010086551A1 (fr) 2009-01-28 2010-01-27 Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
US13/145,665 US8546391B2 (en) 2009-01-28 2010-01-27 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
MA34128A MA33069B1 (fr) 2009-01-28 2010-01-27 Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
PE2011001392A PE20120362A1 (es) 2009-01-28 2010-01-27 Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia
JP2011546921A JP2012516312A (ja) 2009-01-28 2010-01-27 チアジアゾールおよびオキサジアゾール誘導体、これらの調製ならびにこれらの治療用途
KR1020117019841A KR20110112845A (ko) 2009-01-28 2010-01-27 티아디아졸 및 옥사디아졸 유도체, 그의 제조, 및 그의 치료 용도
MX2011007991A MX2011007991A (es) 2009-01-28 2010-01-27 Derivados de tiadiazoles y oxadiazoles, su preparacion y su uso en terapeutica.
AU2010209545A AU2010209545A1 (en) 2009-01-28 2010-01-27 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
BRPI1007414-7A BRPI1007414A2 (pt) 2009-01-28 2010-01-27 derivados de tiadiazóis e de oxadiazóis, o respectivo preparo e a respectiva aplicação em terapêutica
EA201170983A EA201170983A1 (ru) 2009-01-28 2010-01-27 Производные тиадиазолов и оксадиазолов, их получение и их применение в терапии
EP10707597.0A EP2391611B1 (fr) 2009-01-28 2010-01-27 Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
UY0001032405A UY32405A (es) 2009-01-28 2010-01-28 Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapia
TN2011000353A TN2011000353A1 (fr) 2009-01-28 2011-07-15 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique
IL214260A IL214260A0 (en) 2009-01-28 2011-07-24 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
EC2011011224A ECSP11011224A (es) 2009-01-28 2011-07-25 Derivados de tiadiazoles y oxadiazoles, su preparaciòn y su aplicaciòn en terapia
CR20110403A CR20110403A (es) 2009-01-28 2011-07-26 Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia
NI201100149A NI201100149A (es) 2009-01-28 2011-07-27 Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
ZA2011/05525A ZA201105525B (en) 2009-01-28 2011-07-27 Thiadiazole and oxadiazole derivatives,preparation thereof,and therapeutic use thereof
CL2011001839A CL2011001839A1 (es) 2009-01-28 2011-07-28 Compuestos derivados de tiadiazoles y oxadiazoles, inhibidores de la biosintesis de trigliceridos; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento y/o la prevencion de obesidad, dislipidemia, afecciones de alteracion de la glucosa en ayunas, diabetes de tipo 2, entre otras.
DO2011000245A DOP2011000245A (es) 2009-01-28 2011-07-28 Derivados de tiadiazoles y oxadiazoles, su preparacion y su aplicacion en terapeutica
CO11094698A CO6400221A2 (es) 2009-01-28 2011-07-28 Derivados de tidiazoles y oxadiazoles, su preparación y su aplicación en terapia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0904137A FR2949464B1 (fr) 2009-09-01 2009-09-01 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2949464A1 FR2949464A1 (fr) 2011-03-04
FR2949464B1 true FR2949464B1 (fr) 2011-09-30

Family

ID=41821879

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0904137A Expired - Fee Related FR2949464B1 (fr) 2009-01-28 2009-09-01 Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2949464B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007236049A1 (en) * 2006-04-07 2007-10-18 High Point Pharmaceuticals, Llc 11beta-hydroxysteroid dehydrogenase type 1 active compounds
JP2011500563A (ja) * 2007-10-10 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション ジフェニル置換されたシクロアルカン

Also Published As

Publication number Publication date
FR2949464A1 (fr) 2011-03-04

Similar Documents

Publication Publication Date Title
FR2941696B1 (fr) Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2945534B1 (fr) DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2911604B1 (fr) Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2949470B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2926556B1 (fr) Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
FR2928922B1 (fr) Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2953520B1 (fr) Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
FR2903985B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2928921B1 (fr) Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2899586B1 (fr) Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique
FR2891828B1 (fr) Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
FR2952934B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2943669B1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
FR2945533B1 (fr) Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2917412B1 (fr) Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2928149B1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2963005B1 (fr) Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2927625B1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2940284B1 (fr) Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2925901B1 (fr) DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2948369B1 (fr) Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique
FR2902791B1 (fr) Derives d'urees de tropane,leur preparation et leur application en therapeutique
FR2958935B1 (fr) Derives d'heterocycles azotes, leur preparation et leur application en therapeutique humaine

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20170531